A novel model of reproductive and metabolic features of polycystic ovary syndrome
A novel model of reproductive and metabolic features of polycystic ovary syndrome
批准号:
7755393
负责人:
Romana A. Nowak
金额:
$16.63万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-01-07 至 2011-06-30
关键词:
AffectAgeAndrogensAnimal ModelAnovulationAreaBiological MarkersBreedingCardiovascular DiseasesCentral obesityCharacteristicsCholesterolComplexCosmeticsCountryDevelopmentDiabetes MellitusDietDiseaseDyslipidemiasEndocrine System DiseasesEndocrinologyEndometrial CarcinomaEtiologyExhibitsFamily suidaeFatty acid glycerol estersFemaleFunctional disorderGestational DiabetesGlucose IntoleranceGoalsGrowthHealthHigh PrevalenceHirsutismHumanHyperinsulinismHypertensionIndividualInfertilityInsulinInsulin ReceptorInsulin ResistanceKnowledgeLDL Cholesterol LipoproteinsLeadLongevityMedicalMetabolicMetabolic DiseasesMetabolic syndromeMethodologyMiniature SwineModelingMorbidity - disease rateNon-Insulin-Dependent Diabetes MellitusObesityOocytesOvarianOvaryPathogenesisPolycystic Ovary SyndromePregnancy lossProductionReceptor SignalingRecurrenceReproductionResearchResearch PersonnelRiskRoleScientistSymptomsSyndromeTestingTimeWomanWomen&aposs HealthWorkabdominal fatagedbasecardiovascular risk factorcomparativefeedinginnovationinsightnovelpublic health relevancereproductiveresponsetheca cell
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Polycystic ovary syndrome (PCOS) is one of the most common human reproductive endocrine disorders. PCOS is not only a gynecological condition presenting with symptoms such as hirsutism, infertility, recurrent pregnancy loss and endometrial carcinoma, but a comprehensive syndrome with a variety of associated metabolic disorders. Recent recognition of the prominent role of insulin resistance in PCOS has emphasized the metabolic aspects of the disorder and highlighted the associated risks of type II diabetes mellitus (DM) and cardiovascular disease (CVD). The reproductive and metabolic morbidities of PCOS make it an important women's health issue, with medical consequences across the lifespan of affected individuals. However, the etiology and pathogenesis of the syndrome are unclear, and there is no effective cure. Currently, no comparative animal model of PCOS exists that fully embodies the complexity of the syndrome. The objective of this application is to characterize and validate the female Ossabaw pig as a model of PCOS that embodies both the metabolic and reproductive aspects of the syndrome. We hypothesize that the Ossabaw pig is a good comparative animal model of both the metabolic and reproductive mechanisms of PCOS based upon our strong preliminary findings, which demonstrate that female Ossabaw swine naturally develop many characteristics of metabolic syndrome (MS) when fed in excess, and that they develop features of PCOS with MS, namely hyperandrogenemia, enlarged ovaries and altered follicular growth. We plan to accomplish our objective by pursuing a single Specific Aim: Evaluate specific reproductive and metabolic etiologies of PCOS in Ossabaw females fed a diet that induces metabolic syndrome. Reproductively, these include hyperandrogenemia, abnormal theca cell androgen production, altered LH:FSH ratios, cystic ovaries and anovulation. Metabolic parameters include dyslipidemia, glucose intolerance, hyperinsulinemia, and specific alterations in insulin receptor signaling. This team is particularly well prepared to undertake the proposed research, as they have combined expertise in the areas of reproduction, endocrinology, cardiovascular disease and adiposity. The proposed research is innovative in that it will characterize, for the first time, a model for PCOS in which the complex abnormalities of the syndrome can be studied as a whole. The rationale for the proposed research is that characterization of the Ossabaw mini-pig as a model of PCOS will permit significant advances in the field. Researchers will be able to elucidate the pathophysiology of the disease and thus develop management strategies for the immediate symptoms of PCOS, such as infertility, androgen excess and metabolic syndrome, as well as its long term health implications, including endometrial cancer, diabetes and cardiovascular disease. PUBLIC HEALTH RELEVANCE: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in reproductive aged women. Currently, there is no complete animal model that represents both the reproductive and metabolic complexities of the syndrome. Characterization of the Ossabaw mini-pig as a model of PCOS will permit significant advances in the field. Researchers will be able to elucidate the pathophysiology of the disease and thus develop management strategies for the immediate symptoms of PCOS, such as infertility, androgen excess and metabolic syndrome, as well as its long term health implications, including endometrial cancer, diabetes and cardiovascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Glial Cells in Chronic Pelvic Pain of Endometriosis
-
批准号:10251334
-
项目类别:
-
资助金额:$19.02万
-
财政年份:2020
-
负责人:Romana A. Nowak
-
依托单位:
The Role of Glial Cells in Chronic Pelvic Pain of Endometriosis
-
批准号:10062360
-
项目类别:
-
资助金额:$22.99万
-
财政年份:2020
-
负责人:Romana A. Nowak
-
依托单位:
Project 3: Mechanisms that Regulate Growth of Leiomyoma Smooth Muscle Cells
-
批准号:8308001
-
项目类别:
-
资助金额:$44.99万
-
财政年份:2011
-
负责人:Romana A. Nowak
-
依托单位:
Project 3: Mechanisms that Regulate Growth of Leiomyoma Smooth Muscle Cells
-
批准号:8099640
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2010
-
负责人:Romana A. Nowak
-
依托单位:
Project 3: Mechanisms that Regulate Growth of Leiomyoma Smooth Muscle Cells
-
批准号:7752687
-
项目类别:
-
资助金额:$55.31万
-
财政年份:2009
-
负责人:Romana A. Nowak
-
依托单位:
EMMPRIN Regulates Tissue Remodeling in the Endometrium
-
批准号:7315881
-
项目类别:
-
资助金额:$27.02万
-
财政年份:2007
-
负责人:Romana A. Nowak
-
依托单位:
Reactive Oxygen Species Regulate Smooth Muscle Growth*
-
批准号:6740630
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2003
-
负责人:Romana A. Nowak
-
依托单位:
Reactive Oxygen Species Regulate Smooth Muscle Growth
-
批准号:7271158
-
项目类别:
-
资助金额:$29.01万
-
财政年份:2003
-
负责人:Romana A. Nowak
-
依托单位:
Reactive Oxygen Species Regulate Smooth Muscle Growth*
-
批准号:6946886
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2003
-
负责人:Romana A. Nowak
-
依托单位:
Reactive Oxygen Species Regulate Smooth Muscle Growth*
-
批准号:6805747
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2003
-
负责人:Romana A. Nowak
-
依托单位:
Reactive Oxygen Species Regulate Smooth Muscle Growth*
-
批准号:7114917
-
项目类别:
-
资助金额:$29.88万
-
财政年份:2003
-
负责人:Romana A. Nowak
-
依托单位:
EMMPRIN Regulates Tissue Remodeling in the Endometrium
-
批准号:7800262
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2002
-
负责人:Romana A. Nowak
-
依托单位:
EMMPRIN Regulates Tissue Remodeling in the Endometrium
-
批准号:7666694
-
项目类别:
-
资助金额:$25.42万
-
财政年份:2002
-
负责人:Romana A. Nowak
-
依托单位:
EMMPRIN Regulates Tissue Remodeling in the Endometrium
-
批准号:8239991
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2002
-
负责人:Romana A. Nowak
-
依托单位:
EMMPRIN Regulates Tissue Remodeling in the Endometrium
-
批准号:8119170
-
项目类别:
-
资助金额:$24.91万
-
财政年份:2002
-
负责人:Romana A. Nowak
-
依托单位:
PARATHYROID HORMONE-RELATED PROTEIN AND IMPLANTATION
-
批准号:2857479
-
项目类别:
-
资助金额:$8.12万
-
财政年份:1998
-
负责人:Romana A. Nowak
-
依托单位:
PARATHYROID HORMONE-RELATED PROTEIN AND IMPLANTATION
-
批准号:2471455
-
项目类别:
-
资助金额:$8.12万
-
财政年份:1998
-
负责人:Romana A. Nowak
-
依托单位:
EXTRACELLULAR MATRIX PRODUCTION BY UTERINE FIBROIDS
-
批准号:3331806
-
项目类别:
-
资助金额:$5.49万
-
财政年份:1993
-
负责人:Romana A. Nowak
-
依托单位:
EXTRACELLULAR MATRIX PRODUCTION BY UTERINE FIBROIDS
-
批准号:2202823
-
项目类别:
-
资助金额:$16.3万
-
财政年份:1992
-
负责人:Romana A. Nowak
-
依托单位:
EXTRACELLULAR MATRIX PRODUCTION BY UTERINE FIBROIDS
-
批准号:3331804
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1992
-
负责人:Romana A. Nowak
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: